NEWS
- ADC Drugs Global Sales of 2021 and Future Prospects
- Global Sales of ADCs in 2022 – UP to 7 Billion
- GLP-1R Agonists for Weight Loss
- Multi-Arm PEG Hydrogels for Medical Devices
- Clinical Development of ADC Drugs Targeting TROP-2
- PEGylated Liposomes in the Clinic and Clinical Trials
- PROTACs VS. Traditional Small Molecule Inhibitors
- Summary of PROTAC Degraders in Clinical Trials
- FDA Accelerated Approval of ELAHERE™ (mirvetuximab soravtansine-gynx)
- Camptothecin & Its Derivatives for Cancer Therapy